Illumina (ILU) Stock Forecast & Price Target
12 Followers
ILU Analyst Ratings
Moderate Buy
9Buy6Hold3Sell
Based on 18 analysts giving stock ratings to Illumina in the past 3 months
ILU Stock 12 Month Forecast
Average Price Target
EUR 231.81▲(21.48% Upside)Based on 18 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is EUR 231.81 with a high forecast of EUR 275.45 and a low forecast of EUR 177.71. The average price target represents a 21.48% change from the last price of EUR 190.82.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 275.45
AverageEUR 231.81
LowEUR 177.71
Highest Price TargetHighestEUR 275.45Average Price TargetEUR 231.81Lowest Price TargetLowestEUR 177.71
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Catherine Ramsey Schulte | Robert W. Baird | EUR 254.12→EUR 209.70 | hold | 9.89%Upside | Reiterated | 11/05/26 | ||
| Patrick B Donnelly | Citi | EUR 100.41→EUR 186.59 | sell | -2.21%Downside | Reiterated | 11/02/26 | ||
| Ilya Zubkov | Freedom Capital Markets | EUR 164.38→EUR 177.71 | hold | -6.87%Downside | Reiterated | 11/02/26 | ||
| Luke Sergott | Barclays | EUR 177.71 | sell | -6.87%Downside | Reiterated | 10/30/26 | ||
| Daniel Arias | Stifel Nicolaus | EUR 199.92→EUR 266.56 | buy | 39.69%Upside | Reiterated | 10/30/26 | ||
| David Westenberg | Piper Sandler | EUR 271.00 | buy | 42.02%Upside | Reiterated | 10/30/26 | ||
| Kyle Mikson CFA | Canaccord Genuity | EUR 266.56 | hold | 39.69%Upside | Reiterated | 10/30/26 | ||
| Vijay Kumar | Evercore ISI | EUR 257.68→EUR 244.35 | buy | 28.05%Upside | Reiterated | 10/30/26 | ||
| Casey Woodring | J.P. Morgan | EUR 284.33→EUR 266.56 | buy | 39.69%Upside | Reiterated | 10/30/26 | ||
| Lu Li | Bank of America Securities | EUR 149.27→EUR 177.71 | sell | -6.87%Downside | Reiterated | 10/29/26 | ||
| Dan Leonard | RBC Capital | EUR 275.45 | buy | 44.35%Upside | Reiterated | 10/29/26 | ||
| Subbu Nambi | Guggenheim | EUR 271.00 | buy | 42.02%Upside | Reiterated | 10/29/26 | ||
| Mason Carrico | Stephens | EUR 189.26→EUR 244.35 | hold | 28.05%Upside | Downgraded | 10/23/26 | ||
| Eve Burstein | Bernstein | EUR 191.04 | hold | 0.11%Upside | Assigned | 10/19/26 | ||
| Daniel Brennan | TD Cowen | EUR 186.59→EUR 239.91 | hold | 25.72%Upside | Assigned | 10/13/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Catherine Ramsey SchulteRobert W. Baird | HoldReiteratedEUR 254.12→EUR 209.70 | 11/05/26 | 9.89%Upside | ||
| Patrick B DonnellyCiti | SellReiteratedEUR 100.41→EUR 186.59 | 11/02/26 | -2.21%Downside | ||
| Ilya ZubkovFreedom Capital Markets | HoldReiteratedEUR 164.38→EUR 177.71 | 11/02/26 | -6.87%Downside | ||
| Luke SergottBarclays | SellReiteratedEUR 177.71 | 10/30/26 | -6.87%Downside | ||
| Daniel AriasStifel Nicolaus | BuyReiteratedEUR 199.92→EUR 266.56 | 10/30/26 | 39.69%Upside | ||
| David WestenbergPiper Sandler | BuyReiteratedEUR 271.00 | 10/30/26 | 42.02%Upside | ||
| Kyle Mikson CFACanaccord Genuity | HoldReiteratedEUR 266.56 | 10/30/26 | 39.69%Upside | ||
| Vijay KumarEvercore ISI | BuyReiteratedEUR 257.68→EUR 244.35 | 10/30/26 | 28.05%Upside | ||
| Casey WoodringJ.P. Morgan | BuyReiteratedEUR 284.33→EUR 266.56 | 10/30/26 | 39.69%Upside | ||
| Lu LiBank of America Securities | SellReiteratedEUR 149.27→EUR 177.71 | 10/29/26 | -6.87%Downside | ||
| Dan LeonardRBC Capital | BuyReiteratedEUR 275.45 | 10/29/26 | 44.35%Upside | ||
| Subbu NambiGuggenheim | BuyReiteratedEUR 271.00 | 10/29/26 | 42.02%Upside | ||
| Mason CarricoStephens | HoldDowngradedEUR 189.26→EUR 244.35 | 10/23/26 | 28.05%Upside | ||
| Eve BursteinBernstein | HoldAssignedEUR 191.04 | 10/19/26 | 0.11%Upside | ||
| Daniel BrennanTD Cowen | HoldAssignedEUR 186.59→EUR 239.91 | 10/13/26 | 25.72%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Illumina
3 Months
Success Rate21/37 ratings generated profit
57%
Average Return
+5.41%
Copying Daniel Arias's trades and holding each position for 3 Months would result in 56.76% of your transactions generating a profit, with an average return of +5.41% per trade.
1 Year
Success Rate26/33 ratings generated profit
79%
Average Return
+18.18%
Copying Doug Schenkel's trades and holding each position for 1 Year would result in 78.79% of your transactions generating a profit, with an average return of +18.18% per trade.
2 Years
Success Rate24/33 ratings generated profit
73%
Average Return
+47.47%
Copying Doug Schenkel's trades and holding each position for 2 Years would result in 72.73% of your transactions generating a profit, with an average return of +47.47% per trade.
ILU Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 16 | 15 | 17 | 19 | 15 |
| Hold | 9 | 9 | 11 | 11 | 11 |
| Sell | 7 | 5 | 4 | 7 | 6 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 32 | 29 | 32 | 37 | 32 |
In the current month, ILU has received 15 Buy Ratings, 11 Hold Ratings, and 6 Sell Ratings. ILU average Analyst price target in the past 3 months is 231.81.
ILU Financial Forecast
HighEUR 1.39
ConsensusEUR 1.36
LowEUR 1.34
ILU Earnings Forecast
Next quarter’s earnings estimate for ILU is EUR 1.36 with a range of EUR 1.34 to EUR 1.39. The previous quarter’s EPS was EUR 1.28. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 1.1B
ConsensusEUR 1.09B
LowEUR 1.08B
ILU Sales Forecast
Next quarter’s sales forecast for ILU is EUR 1.09B with a range of EUR 1.08B to EUR 1.10B. The previous quarter’s sales results were EUR 1.01B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
ILU Stock Forecast FAQ
What is DE:ILU’s average 12-month price target, according to analysts?
Based on analyst ratings, Illumina’s 12-month average price target is €231.81.
What is DE:ILU’s upside potential, based on the analysts’ average price target?
Illumina has 21.48% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Illumina a Buy, Sell or Hold?
Illumina has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 6 hold ratings and 3 sell ratings.
What is Illumina’s share price target?
The average share price target for Illumina is €231.81. This is based on 18 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €275.45, and the lowest forecast is €177.71. The average share price target represents a 21.48% increase from the current price of €190.82.
What do analysts say about Illumina?
Illumina’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 18 Wall Street analysts.
How can I buy shares of Illumina?
To buy shares of DE:ILU, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
